AbbVie (NYSE:ABBV) Stock Gets Price Target Bump From JPMorgan Chase & Co.

AbbVie (NYSE:ABBV) Price Target Raised to $290.00

Cantor Fitzgerald boosted their price target on AbbVie from $285.00 to $290.00 and gave the company an "overweight" rating in a research note on Thursday.

AbbVie (NYSE:ABBV) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says

AbbVie (NYSE:ABBV – Get Free Report) had its target price hoisted by Cantor Fitzgerald from $285.00 to $290.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Cantor Fitzgerald’s target price points to a potential upside of 6.87% from the stock’s […]